Silje Nord from the Genome variation group, Department of Genetics at the Institute for Cancer Research has been awarded a prestigious career grant from Helse Sør-Øst for the proposal "Making sense of GWAS data". The grant amounts to NOK 2 million per year and runs for 4 years.
Published in major journals, first or last author from Oslo University Hospital.
A Trial of a Transglutaminase 2 Inhibitor in Celiac Disease. Reply
N Engl J Med, 385 (16), e57
No Strong Evidence on Liver Transplant for Colorectal Cancer Liver Metastasis Over Portal Vein Embolization Associated With Liver Resection-Reply
JAMA Surg (in press)
Urinary Extracellular Vesicles in Urology: Current Successes and Challenges Ahead
Eur Urol (in press)